The use of psychoactive drugs without medical supervision is associated with significant health risks and can lead to the development of drug use disorders. Drug use disorders, particularly when untreated, increase morbidity and mortality risks for individuals, can trigger substantial suffering and lead to impairment in personal, family, social, educational, occupational or other important ...
The Unit works globally to improve health and well-being of populations by articulating, promoting, supporting and monitoring evidence-informed policies, strategies and interventions to reduce the burden associated with alcohol, drugs and addictive behaviours.
Publications of the World Health Organization Home / Publications / Overview / Canada: A List of Essential Prescription Drugs and Related Products-Initial Recommendation 2025 (English)
This report presents the first World Health Organization (WHO) analysis of antifungal agents in preclinical and clinical development. It covers systemic antifungal drugs in development worldwide, including label extension and repurposed products, and critically evaluates how well the current pipeline addresses infections caused by WHO fungal priority pathogens.
Alcohol and drugs are specifically mentioned under health target 3.5: “Strengthen the prevention and treatment of substance use, including narcotic drug abuse and harmful use of alcohol”.
EurekAlert!: Promising heart drugs ID'd by cutting-edge combo of machine learning, human learning
Promising heart drugs ID'd by cutting-edge combo of machine learning, human learning
The U.S. Centers for Medicare & Medicaid Services (CMS) announced the selection of 15 high-cost prescription drugs for the third cycle of the Medicare Drug Price Negotiation Program, marking the first ...
Morningstar: Obesity Drugs: Can New Firms Take Market Share From Eli Lilly and Novo Nordisk?
Obesity Drugs: Can New Firms Take Market Share From Eli Lilly and Novo Nordisk?